Essex Investment Management CO LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Essex Investment Management CO LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$65.78 - $105.02 $1.08 Million - $1.73 Million	-16,485 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$64.07 - $91.75 $1.06 Million - $1.51 Million	16,485 New	16,485 $1.13 Million
Q4 2020 Feb 12, 2021	SELL	$65.07 - $98.24 $2.16 Million - $3.25 Million	-33,130 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$59.04 - $77.95 $779,268 - $1.03 Million	-13,199 Reduced 28.49%	33,130 $2.15 Million
Q2 2020 Aug 04, 2020	SELL	$29.01 - $74.23 $636,305 - $1.63 Million	-21,934 Reduced 32.13%	46,329 $3.39 Million
Q1 2020 May 04, 2020	BUY	$27.51 - $57.29 $454,107 - $945,686	16,507 Added 31.89%	68,263 $2.32 Million
Q4 2019 Feb 10, 2020	BUY	$40.86 - $57.65 $605,953 - $854,949	14,830 Added 40.16%	51,756 $2.82 Million
Q3 2019 Oct 22, 2019	SELL	$37.38 - $49.47 $290,068 - $383,887	-7,760 Reduced 17.37%	36,926 $1.54 Million
Q2 2019 Aug 15, 2019	BUY	$39.79 - $67.01 $714,827 - $1.2 Million	17,965 Added 67.23%	44,686 $1.96 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $922,408 - $1.42 Million	26,721 New	26,721 $1.38 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.